Back to search
Oral Uremic Toxin Absorbent
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Oral Uremic Toxin Absorbent trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Oral Uremic Toxin Absorbent trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Diabetes mellitus (DM) is a chronic inflammatory disease characterized by insufficient insulin secretion or insulin resistance, leading to hyperglycemia. Chroni…
In patients with chronic kidney disease (CKD), uremic toxins accumulate when kidney function declines. Those uremic toxins had a greater affinity to circulating…
Taiwan has more chronic kidney disease (CKD) per capita than anywhere in the world, leading to the highest expense of National Health Insurance. By reviewing pr…
Participants with chronic kidney disease (CKD) are at a higher risk of developing atherosclerotic peripheral artery disease (PAD). Retention of uremic toxins su…